Glycopyrrolate/formoterol fumarate metered dose inhaler for maintenance-naïve patients with chronic obstructive pulmonary disease: a post-hoc analysis of the randomized PINNACLE trials.
Jinping ZhengJin-Fu XuMartin JenkinsPryseley Nkouibert AssamLijiao WangBrian J LipworthPublished in: Respiratory research (2020)
NMT patients achieved better lung function with GFF versus monotherapy and placebo, without increased safety risk. Dual bronchodilator therapy may offer better outcomes than monotherapy for COPD patients when administered as first-line treatment.
Keyphrases
- lung function
- end stage renal disease
- newly diagnosed
- ejection fraction
- chronic obstructive pulmonary disease
- chronic kidney disease
- open label
- prognostic factors
- peritoneal dialysis
- cystic fibrosis
- double blind
- clinical trial
- stem cells
- combination therapy
- type diabetes
- adipose tissue
- bone marrow
- phase iii
- phase ii
- weight loss